Clinical Assessment of Pain, Tolerability, and Preference of an Autoinjection Pen Versus a Prefilled Syringe for Patient Self-Administration of the Fully Human, Monoclonal Antibody Adalimumab: The TOUCH Trial
Authors:
- Alan KivitzAKAlan Kivitz
- Steven CohenSCSteven Cohen
- James Edward DowdJDJames Edward Dowd
- William EdwardsWEWilliam Edwards
- Suman ThakkerSTSuman Thakker
- Frank R. WellborneFWFrank R. Wellborne
- Cheryl L. RenzCRCheryl L. Renz
- Oscar G. SeguradoOSOscar G. Segurado
- 1 October 2006
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 28 (10) , 1619-1629
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2006
- Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended studyAnnals of the Rheumatic Diseases, 2006
- The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatmentArthritis & Rheumatism, 2005
- Does route of administration affect the outcome of TNF antagonist therapy?Arthritis Research & Therapy, 2004
- Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo‐controlled, 52‐week trialArthritis & Rheumatism, 2004
- Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitusClinical Therapeutics, 2004
- A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitusClinical Therapeutics, 2003
- Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: A pilot studyClinical Therapeutics, 2003
- Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trialArthritis & Rheumatism, 2003
- Practicability and Acceptance of Subcutaneous Self‐administration of the Selective Serotonin Agonist SumatriptanHeadache: The Journal of Head and Face Pain, 1998